BCTX
NASDAQ · Biotechnology
Briacell Therapeutics Corp
$4.18
+0.01 (+0.24%)
Open$4.13
Previous Close$4.17
Day High$4.24
Day Low$4.05
52W High$23.94
52W Low$17.50
Volume—
Avg Volume87.2K
Market Cap35.59M
P/E Ratio—
EPS$0.27
SectorBiotechnology
Analyst Ratings
Strong Buy
5 analysts
Price Target
+492.1% upside
Current
$4.18
$4.18
Target
$24.75
$24.75
$18.09
$24.75 avg
$34.06
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 6.36M | 5.82M | 6.86M |
| Net Income | -563,828 | -513,311 | -545,732 |
| Profit Margin | -8.9% | -8.8% | -8.0% |
| EBITDA | -665,396 | -604,117 | -725,268 |
| Free Cash Flow | -534,078 | -494,442 | -500,696 |
| Rev Growth | -7.7% | -7.5% | +13.8% |
| Debt/Equity | 0.28 | 0.30 | 0.25 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |